Insulin and glucagon during pentobarbitone anaesthesia

Area of Science:

• Endocrinology
• Anesthesiology
• Metabolic research

Background:

• Anesthesia can significantly impact metabolic processes.
• Understanding the effects of anesthetics on glucose homeostasis is crucial for patient care and research.

Purpose of the Study:

• To investigate the effects of sodium pentobarbital anesthesia on glucose metabolism and hormonal responses in mice.
• To elucidate the role of insulin and glucagon in mediating these changes during and after anesthesia.

Main Methods:

• Mice were fasted for 18 hours before anesthesia induction with sodium pentobarbital (45 mg/kg, ip).
• Plasma glucose, insulin, glucagon, and free fatty acid levels were measured.
• Glucose tolerance tests, insulin response to glucose and glucagon, and insulin tolerance tests were performed during and after anesthesia.

Main Results:

• Anesthesia induced transient hyperglycemia and persistently elevated plasma glucagon, with rising insulin levels over time.
• Impaired glucose tolerance and enhanced insulin response were observed during anesthesia.
• All parameters normalized four hours post-recovery, except for improved glucose tolerance compared to controls.

Conclusions:

• Pentobarbital anesthesia disrupts glucose homeostasis through alterations in insulin and glucagon secretion and action.
• These hormonal changes contribute to impaired glucose metabolism during anesthesia.
• Recovery from anesthesia leads to normalization of metabolic parameters, with a notable improvement in glucose tolerance.